Drug Trial Radar · NCT00002755
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
Last checked: Nov 19, 2026Latest source record: Nov 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Planned (sponsor's estimate)
Start
Nov 1995
Primary completion
Not stated
Study completion Jun 1999
Sponsor
- Lead sponsor
- Scottish Cancer Therapy NetworkAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 24, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more tumor cells. It is not yet known which treatment regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of standard cyclophosphamide, methotrexate, and fluorouracil with that of high-dose combination chemotherapy plus peripheral stem cell transplantation in treating women who have stage II or stage IIIA breast cancer.
Conditions
- Breast Cancer
Interventions
filgrastimBiological
CMF regimenDrug
cyclophosphamideDrug
doxorubicin hydrochlorideDrug
fluorouracilDrug
methotrexateDrug
tamoxifen citrateDrug
thiotepaDrug
autologous bone marrow transplantationProcedure
peripheral blood stem cell transplantationProcedure
low-LET cobalt-60 gamma ray therapyRadiation
low-LET electron therapyRadiation
low-LET photon therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
St. Vincent's Hospital
Dublin, Ireland
Addenbrooke's NHS Trust
Cambridge, England, United Kingdom
Cheltenham General Hospital
Cheltenham, England, United Kingdom
Royal Devon and Exeter Hospital
Exeter, England, United Kingdom
Royal Free Hospital
Hampstead, London, England, United Kingdom
Northwick Park Hospital
Harrow, England, United Kingdom
Huddersfield Royal Infirmary
Huddersfield, West Yorks, England, United Kingdom
St. James's Hospital
Leeds, England, United Kingdom
St. George's Hospital
London, England, United Kingdom
Middlesex Hospital- Meyerstein Institute
London, England, United Kingdom
Newcastle General Hospital
Newcastle upon Tyne, England, United Kingdom
Nottingham City Hospital NHS Trust
Nottingham, England, United Kingdom
Derriford Hospital
Plymouth, England, United Kingdom
Weston Park Hospital
Sheffield, England, United Kingdom
Royal South Hants Hospital
Southampton, England, United Kingdom
Aberdeen Royal Infirmary
Aberdeen, Scotland, United Kingdom
Royal Infirmary
Edinburgh, Scotland, United Kingdom
Western General Hospital
Edinburgh, Scotland, United Kingdom
Beatson Oncology Centre
Glasgow, Scotland, United Kingdom
Royal Infirmary
Glasgow, Scotland, United Kingdom
Velindre Hospital
Cardiff, Wales, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.